tiprankstipranks
Advertisement
Advertisement
Ascentage Pharma assumed with an Outperform at Oppenheimer
PremiumThe FlyAscentage Pharma assumed with an Outperform at Oppenheimer
1M ago
Ascentage Pharma announces clinical updates from EHA2026
Premium
The Fly
Ascentage Pharma announces clinical updates from EHA2026
2M ago
Ascentage Pharma initiated with a Buy at B. Riley
Premium
The Fly
Ascentage Pharma initiated with a Buy at B. Riley
2M ago
Ascentage Pharma: Buy Rating Reiterated on Advancing CML/ALL Pipeline and DCF-Supported Unchanged $48 Price Target
PremiumRatingsAscentage Pharma: Buy Rating Reiterated on Advancing CML/ALL Pipeline and DCF-Supported Unchanged $48 Price Target
3M ago
Ascentage Pharma to Present 17 Hematology Clinical Updates at June 2026 EHA Congress
Premium
Company Announcements
Ascentage Pharma to Present 17 Hematology Clinical Updates at June 2026 EHA Congress
3M ago
Ascentage Pharma to Highlight Oncology Portfolio at May–June 2026 Investor Conferences
Premium
Company Announcements
Ascentage Pharma to Highlight Oncology Portfolio at May–June 2026 Investor Conferences
3M ago
Ascentage Pharma initiated with a Buy at BTIG
PremiumThe FlyAscentage Pharma initiated with a Buy at BTIG
5M ago
Ascentage Pharma: Undervalued Long-Term Oncology Leader Backed by Late-Stage Assets Olverembatinib and Lisaftoclax
Premium
Ratings
Ascentage Pharma: Undervalued Long-Term Oncology Leader Backed by Late-Stage Assets Olverembatinib and Lisaftoclax
5M ago
Ascentage Pharma Sets March 25, 2026 Date to Unveil 2025 Unaudited Results and Business Update
Premium
Company Announcements
Ascentage Pharma Sets March 25, 2026 Date to Unveil 2025 Unaudited Results and Business Update
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100